Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by MustangSalleyon Aug 16, 2021 1:33pm
150 Views
Post# 33710733

RE:Sernova can easily afford to drive business growth.

RE:Sernova can easily afford to drive business growth.

rixpix wrote: Don't know of anyone's seen this. It's a few days old. Worth the read.... https://simplywall.st/stocks/ca/pharmaceuticals-biotech/tsxv-sva/sernova-shares/news/we-think-sernova-cvesva-can-easily-afford-to-drive-business

 

Rip,

Thanks for posting that . It is a purely amateur assessment of Sva . Firstly , Thayer Sva listed on Cse not Tsx Venture exchange. Their assessment that annual 6.1 million burn rate will last 5 years before they will have to raise money is unrealistic . Toleisikiscis doubling the staff and any clinica
 studies for Thyorid or even an expansion of the current Fda trial will eat up that money within a year . To expand the current clinical trial to get orphan status for brittle diabetics will need a minimum of 30 patients . It's taken 3 years to get 6 patients , so Toleikis will do another raise in a year or two imo ..... float will hit 500 million shares and God help us if he decides to reward himself and Hollar with more options with a job well done .

Ms Mustang Sally 

<< Previous
Bullboard Posts
Next >>